Caner İşevi, MD
7
1
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Effectiveness of an Innovative Chest Stabilizer in Rib Fracture Treatment: Impact on Respiratory Function, Complications, and Clinical Outcomes
Role: lead
Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance
Role: lead
Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery
Role: lead
Major Vascular Injuries in Elective Thoracic Surgery: A 10-Year Single-Center Experience
Role: lead
Evaluation of Diagnosis and Treatment Methods in Corrosive Esophagitis: A 26-Year Experience-Based Algorithm
Role: lead
Ultrasound for Diagnosing Costochondral Joint Separation
Role: lead
Mortality Causes in Rib Surgery Patients
Role: lead
All 7 trials loaded